Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1518 (119th)

New Era of Preventing End-Stage Kidney Disease Act

referredUnited States· United States Congress· EN

Introduced

24 February 2025

Last action

24 February 2025 · Introduced

Status

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Rep. Bilirakis, Gus M. [R-FL-12], Rep. Sewell, Terri A. [D-AL-7], Rep. Miller, Carol D. [R-WV-1], Rep. Peters, Scott H. [D-CA-50], Rep. Balderson, Troy [R-OH-12], Rep. Tonko, Paul [D-NY-20], Rep. Schneider, Bradley Scott [D-IL-10], Rep. Davis, Danny K. [D-IL-7], Rep. Lieu, Ted [D-CA-36], Rep. Dunn, Neal P. [R-FL-2], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Crenshaw, Dan [R-TX-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Brownley, Julia [D-CA-26], Rep. Obernolte, Jay [R-CA-23], Rep. Lawler, Michael [R-NY-17], Rep. Castor, Kathy [D-FL-14], Rep. Davis, Donald G. [D-NC-1], Rep. Wilson, Joe [R-SC-2], Rep. Tlaib, Rashida [D-MI-12], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Ryan, Patrick [D-NY-18], Rep. Nadler, Jerrold [D-NY-12], Rep. Garbarino, Andrew R. [R-NY-2], Rep. Bishop, Sanford D. [D-GA-2], Rep. Correa, J. Luis [D-CA-46], Rep. McGovern, James P. [D-MA-2], Rep. Jackson, Jonathan L. [D-IL-1], Rep. Crow, Jason [D-CO-6], Rep. Soto, Darren [D-FL-9], Rep. Lofgren, Zoe [D-CA-18], Rep. Green, Al [D-TX-9], Rep. Ross, Deborah K. [D-NC-2], Rep. Menendez, Robert [D-NJ-8], Rep. McBride, Sarah [D-DE-At Large], Rep. Kim, Young [R-CA-40], Rep. Ocasio-Cortez, Alexandria [D-NY-14], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Ivey, Glenn [D-MD-4], Rep. Stevens, Haley M. [D-MI-11], Rep. Carey, Mike [R-OH-15], Rep. Flood, Mike [R-NE-1], Rep. Cuellar, Henry [D-TX-28], Rep. Vasquez, Gabe [D-NM-2], Rep. Kiggans, Jennifer A. [R-VA-2], Rep. Lee, Susie [D-NV-3]

Subjects

Healthcare, Education

Source updated

21 August 2026

Healthcare · Education

Summary

New Era of Preventing End-Stage Kidney Disease Act This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease. Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.  The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations. Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease. Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 24 February 2025

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 24 February 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 24 February 2025

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

Introduced in House

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Volledige documentvertaling met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    Introduced in House · EN · 24 February 2025

    ViewDownloadOpen at official source

  • Introduced in House

    summary · EN · 24 February 2025

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Volledige documentvertaling met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 64 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.